Telaprevir Open-Label Study in Co-Infected Patients

NCT01500616 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Telaprevir
DRUG: Telaprevir

Sponsor

Janssen-Cilag International NV